Bristol-Myers Squibb
BMY
#178
Rank
C$170.77 B
Marketcap
C$83.55
Share price
-2.05%
Change (1 day)
29.93%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): C$6.36

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$6.47. In 2025 the company made an earnings per share (EPS) of C$4.95 an increase over its 2024 EPS that were of C-$6.33.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.3628.3%
2025C$4.95-178.28%
2024C-$6.33-213.92%
2023C$5.5630.2%
2022C$4.27-6.04%
2021C$4.54-179.29%
2020C-$5.73-281.37%
2019C$3.16-27.21%
2018C$4.34
2016C$3.82175.26%
2015C$1.39-19.83%
2014C$1.73-22.44%
2013C$2.2334.48%
2012C$1.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.38 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.24 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.89 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$3.38-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.20 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK